Credit: Shutterstock photoTop Health-care stocks:
JNJ: flat
PFE: -0.3%
ABT: flat
MRK: flat
AMGN: flat
Health-care shares were mainly unchanged in pre-market trade Tuesday.
In health-care stocks news, Atara Biotherapeutics ( ATRA ) said Tuesday that its ATA230 has been granted orphan drug designation for the treatment of cytomegalovirus (CMV) viremia and disease in immunocompromised patients by the U.S. Food and Drug Administration.
Shares in the company were unchanged at $15.25 in early trade. The stock has traded between $11.80 and $23 over the past 52 weeks.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
